Introduction
Animal models of infection make possible the study virulence determinants of important human pathogens in the context of an active host immune response. Murine model systems in particular offer the advantages of genetic tractability, and a well-characterized immune response. Additionally, a multitude of reagents has been developed for these models, including mutant mouse strains, antibodies, and cytokines to fully characterize host/pathogen interactions. However, mouse model systems can pose challenges in that infection via a specific route does not always mimic the disease or pathology elicited by an infectious agent in a human host. Therefore, lung models have been developed to provide an alternate approach for investigating enteric bacterial pathogenesis. The rationale for these studies is that, like the intestine, the lung is a site of mucosal immunity. Obviously, there are profound differences between these two mucosal environments. For instance, a bottleneck of colonization in an orogastric infection is the gastric barrier, whereas in intranasal infection, the ciliated mucosa lining the upper respiratory tract acts as a physical barrier. Additionally, the pH encountered by a typical gastrointestinal pathogen ranges greatly from acidic in the stomach to basic in the large intestine. The lungs, however, remain uniform in pH. Importantly, lungs are generally a sterile environment and therefore do not mimic the conditions of the GI mucosal environment where competing flora abound, and influence the course of infection (Logsdon & Mecsas, 2006; Magalhaes et al., 2007) . Despite these and other differences, lung models of infection have has served to model some aspects of enteric infections in cases where there is no ideal model system. These models complement cell culture studies of host/pathogen interaction, particularly in identifying virulence factors, determining host response, and developing vaccine strategies.
Naturally occurring lung pathogens models have been developed for genera including Yersinia, Francisella, Bordetella, Pseudomonas, Klebsiella, and Burkholderia and have been characterized extensively (van Gent et al., 2011; Hoffmann et al., 2005; Lathem et al., 2005; Lawlor et al., 2005; Rick Lyons & Wu, 2007; Wiersinga et al., 2006) . Generally, infection models of natural pulmonary pathogens are characterized by a low lethal dose, systemic spread, and an increase in bacterial burden (Table 1) . Characterizations of infections with these organisms provide an important comparator for nonpulmonary pathogens. Here, we discuss the models that have been developed for studying enteric pathogens in the context of a pneumonic infection.
Naturally occurring lung pathogens

Yersinia pestis
Plague has been extensively studied over the past several decades both by epidemiology of human infection and a wide variety of animal models (Smith, 1959a, b; Fingold, 1969; von Reyn et al., 1977; Davis et al., 1996; Lathem et al., 2005; Begier et al., 2006) . Progression of murine pneumonic plague was described in mice in 1959 (summarized in Table 1 ; Smith, 1959a, b) . However, only recently has a pneumonic infection in mice been thoroughly characterized in terms of host and bacterial response at the molecular level (Lathem et al., 2005) . As a natural host for Yersinia, the mouse model of infection closely mimics that seen human disease. After intranasal inoculation with 1 9 10 4 CFU, 75% of the inoculum is recovered from the lungs 24 h postinoculation. Whether this reduction is due to a physical bottleneck in bacteria reaching the lungs or active killing by the host is unclear. Regardless, by 72 h postinoculation, bacteria rapidly replicate to 10 9 10 10 CFU per lung (Lathem et al., 2005; Smith, 1959a, b) , at which point mice were moribund or had already succumbed to infection. Despite the presence of bacteria, lung histology is indistinguishable from uninfected mice until 48 h postinfection. This is likely due to the lack of inflammatory response elicited by the bacteria in the early course of infection Lathem et al., 2005) . By 48 h postinoculation, however, severe histopathology is observed, including influx of neutrophils, edema, and tissue consolidation. No colonization of the spleen is observed until 36 h postinoculation indicating that the bacteria do not disseminate before this or that the host is able to quickly kill those that do. By this time, viable bacteria are detectable at levels of 100 CFU per spleen and increase to 1 9 10 9 CFU per spleen by 72 h postinoculation. All virulence and pathology is dependent on the Yersinia virulence plasmid as a plasmid minus strain is avirulent in mice (Lathem et al., 2005) .
The enormous bacterial burdens associated with this model of infection allow for the detailed analysis of the bacterial transcriptome during infection (Lathem et al., 2005) . These analysis revealed that a number of metabolic and virulence associated genes were upregulated in lung tissue 48 h postinoculation compared with growth in broth cultures (Lathem et al., 2005) . Similar analysis of splenic colonization would be greatly informative if tissue-specific bacterial transcriptomes were available. For instance, it was noted that the psa operon was downregulated in the lungs. As psaA is important for the colonization of the spleen following intranasal inoculation, it would be interesting to know whether upregulation took place there (Cathelyn et al., 2006) . Such analysis would enhance our understanding of how Yersinia is able to colonize different host tissues, perhaps allowing for novel therapeutics targeting virulence factors necessary in multiple organs.
Another feature of the Y. pestis intranasal infection model is that mice can be protectively immunized, allowing for a greater understanding of host response (Smith, 1959a, b) . Much of the early work in vaccine development focused on subcutaneous injection of heat killed bacteria or live attenuated vaccines such as the EV76 strain (for review see Smiley, 2008) . The EV76 strain lacks an iron acquisition locus rendering it greatly attenuated, even in the presence (Jackson & Burrows, 1956; Une & Brubaker, 1984) . However, EV76 has not proven to be very efficacious as a live attenuated vaccine and is associated with severe side effects (Bartelloni et al., 1973; Meyer, 1970) . On the other hand, recombinant vaccines using the F1 component of capsule and LcrV of the TTSS generate a strong protective response against intranasal challenge in mice (Eyles et al., 2000; Smiley, 2008; Tripathi et al., 2006; Williamson et al., 1997) . However, new interest has been generated in live attenuated vaccines as avirulent, protective mutants continue to be uncovered. For instance, mice infected with LpxL + Y. pestis are protected from subsequent intranasal or subcutaneous challenge (Montminy et al., 2006) . Additionally, Y. pestis DyopH is avirulent in pneumonic infection . Yersinia pestis DyopH-infected mice are better able to survive subsequent pneumonic or bubonic infections . Thus, models of pneumonic plague inform as to the role of adaptive immunity for vaccine development.
Francisella tularensis
Like Y. pestis, F. tularensis is a highly infectious respiratory and lymphatic pathogen maintained in a sylvatic reservoir and transmitted through an arthropod vector (deer flies), by aerosol, or handling of infected animals. As little as 10 CFU are capable of causing life-threatening respiratory illness, which can lead to systemic colonization. The symptoms of tularemia vary with the route of inoculation, but generally include pneumonia, fever, headache, and swollen glands (Matyas et al., 2007; Sjostedt, 2007) . Unlike plague, however, tularemia is not known to be transmissible from person to person and has adopted an intracellular lifestyle (Sjostedt, 2007) .
The mouse model of infection closely mimics human disease. Both F. tularensis Types A and B can cause mouse and human disease, but Type A infection has a much higher prevalence in human infection (Rick Lyons & Wu, 2007) . Mice intranasally inoculated with as little as 8 CFU of Type A succumb to infection within 7 days in various mouse backgrounds (Wu et al., 2005) . In fact, only DBA/2 mice showed modest resistance to this low dose, while BALB/c, C57BL/6, and C3H/HeN mice were exquisitely sensitive, suggesting that this model of infection is not strain-dependent (Wu et al., 2005) . Similar experiments were conducted with two separate Type A strains with similar results, suggesting that this is not a bacterial strain-specific phenomena either (Conlan et al., 2003) . Following aerosol infection with 200 CFU, lungs were colonized to > 1 9 10 10 CFU per lung by 5 days (Conlan et al., 2003) . Systemic organs of mice were colonized 48 h postinoculation and remained colonized until mice succumbed. As expected mice inoculated with the vaccine strain, LVS, were able to clear systemic infection after 2 weeks, although survival is dose-dependent (Wu et al., 2005) . The fact that Type A causes disease, while the vaccine strain does not is consistent with human studies, further supporting the idea that this infection model mimics human infection (Rick Lyons & Wu, 2007) . A working murine model of infection for tularemia-facilitated discovery of specific bacterial virulence factors, and the role of the innate immune system for countering them (Rick Lyons & Wu, 2007) .
Vaccination studies using the murine lung model of F. tularensis infection shed light both on the role of adaptive immunity and on disease prevention (Wu et al., 2005) . Such a model prevents the necessity of human volunteers such as the prisoner "volunteers" employed for the development of the LVS vaccine strain (Hornick & Eigelsbach, 1966) . Intranasal inoculation with the LVS vaccine strain can protect BALB/c mice from intranasal or subcutaneous challenge with virulent F. tularensis (Wu et al., 2005) . However, C57BL/6 mice are less protected in these assays. This result may suggest a mixed efficacy in human populations. Using purified antigen is another approach being utilized to develop and efficacious vaccine. For instance, in TraSH studies, many attenuated mutants were identified (Weiss et al., 2007) . Among the genes identified, LPS and O-antigen were biosynthetic genes. Subunit vaccines to these antigens have been used with some success (Wayne Conlan & Oyston, 2007) ; however, they are generally not protective for all Francisella subspecies. By making subunit vaccines from novel virulence factors identified in these studies a more broad range pulmonary vaccine may be developed.
Bordetella pertussis and Bordetella bronchiseptica
Bordetella pertussis is the causative agent of whooping cough, a severe respiratory disorder characterized by a contagious chronic cough, which can be fatal in infants (Markov & Crowcroft, 2007) . In humans, limited histopathology available suggests that bacteria line the lung bronchioles and form lesions in the epithelium (Elahi et al., 2007; Mallory & Horner, 1912) . Bordetella pertussis is an obligate human pathogen and has no natural animal host. Animal models-from mice to pigs to puppies-have been employed with some success, yet none completely mimic the human disease (Elahi et al., 2007) . Although B. bronchiseptica has only been shown to affect severely immunocompromised people, it induces a more severe infection in mice and has been used in murine infections to model B. pertussis human disease (Elahi et al., 2007) . After receiving 1 9 10 5 CFU, wild-type mice can clear most of a B. pertussis infection within 30 days (Table 1 ; Khelef et al., 1994; Vandebriel et al., 2003) . This process takes almost 60 days in a B. bronchiseptica infection (Harvill et al., 2000) . Additionally, infection with B. bronchiseptica induces a much more intense histopathology than B. pertussis in mice (Harvill et al., 1999; Khelef et al., 1994; Vandebriel et al., 2003) . Histopathology during B. bronchiseptica infection generally consists of inflammation, of the lungs and recruitment of neutrophils around the bronchioles (Harvill et al., 1999) . As with human infection, murine infections are not lethal by intranasal routes of inoculation, however, infection of SCID mice or infection by the intracranial route (a meningitis model) can be lethal (Burns et al., 2003; Harvill et al., 1999) . Similarly, IL-4 À/À and IFN-cR À/À intranasally inoculated mice clear B. pertussis as well as wild-type mice, while Ig À/À could not clear the infection even after 3 months (Mahon et al., 1997) . Using mutant mice in such experiments, the host factors important in immunity will continue to be elucidated.
Although Bordetella murine lung infections do not model all symptoms of whooping cough [e.g. unlike piglets, mice are not able to cough (Elahi et al., 2007) ], such experiments have been invaluable in determining the role of virulence factors in causing disease as well as in identifying potential vaccine components. For example, a B. pertussis Dfim mutant strain, which lacks the fimbrial adhesin, is cleared more rapidly than a wild-type strain following intranasal inoculation (Vandebriel et al., 2003) . Additionally, a B. parapertussis O-antigen mutant is more rapidly cleared from the lung (Burns et al., 2003) . As Bordetella species all differ in O-antigen structure comparing differential antigens may lead to a better understanding of how pathogens evolve to broaden host range.
Pseudomonas aeruginosa
Pseudomonas aeruginosa is an important opportunistic pathogen associated with nosocomial infection. Pseudomonas forms biofilms, making it highly resistant to antibiotics, on catheters and other medical devices, such as ventilator tubes. Like Yersinia, P. aeruginosa employs a type three secretion system to intoxicate host cells. Chronic infection can develop in exposed immunocompromised individuals (Sadikot et al., 2005) . Burn victims are especially vulnerable to bacteremia (Ressner et al., 2008) , while ventilated or cystic fibrosis patients are at higher risk of contracting chronic pneumonia caused by P. aeruginosa (MoreauMarquis et al., 2008) .
As neither healthy humans nor rodents are natural hosts for Pseudomonas, it is not surprising that murine lung models do not efficiently reproduce human disease (which is generally limited to immunocompromised individuals). Additionally, infections tend to be dependent on both the mouse and bacterial strains. C57BL/6 mice infected with 1 9 10 7 CFU P. aeruginosa clear the majority of CFU by 24 h postinoculation (Table 1; Power et al., 2004) . Infected mice show a marked increase in neutrophil recruitment at this time, suggesting that unlike Y. pestis Lathem et al., 2005) , P. aeruginosa does not actively inhibit migration of PMNs at early time points. In fact, P. aeruginosa infected mice show an increase in inflammatory cytokines such as MIP-2 and TNF production 4 h postinoculation (Power et al., 2004) . CH3/HeJ mice infected with a nonlethal dose (LD 50 in this model is 1 9 10 7 CFU) of P. aeruginosa did not develop chronic pneumonia, and cleared the bacteria over the course of 2 weeks (George et al., 1993) . Interestingly, this was true for seven different bacterial strains tested, suggesting that the lack of chronic infection is not due to the strain of bacteria, but rather the host background.
Mutant mice that mimic cystic fibrosis allow for the investigation of human infection. Infections of CFTR À/À mice better mimic what is observed in human infection with Pseudomonas. Upon infection with 4 9 10 6 CFU, bacteria replicate over the course of 7 days, over which time 65% of mice succumb to pneumonia (Hoffmann et al., 2005) . This infectious dose is sublethal to wild-type BALB/c mice. Although efforts in vaccine development are underway for CF patients, P. aeruginosa is a nosocomial pathogen, and therefore, vaccine development is not a high priority, or perhaps even not advisable (Doring & Pier, 2008) . However, pulmonary models of infection will allow for testing novel therapeutics and treatment regimens. For instance, in TTSS mutants that cannot secrete effectors are outcompeted by wild-type bacteria in the lungs and spleens of neutropenic mice following intranasal inoculation (Vance et al., 2005) . Targeting virulence factors, such as the TTSS, is an emerging paradigm in antimicrobial chemotherapy (Clatworthy et al., 2007) .
Klebsiella pneumoniae
Klebsiella pneumoniae is a nosocomial, human pathogen associated with urinary tract infection, pneumonia, and the infection of burn wounds (de Macedo et al., 2003; Podschun & Ullmann, 1998) . The vast majority of infection with K. pneumoniae occurs in immunocompromised patients, including chronic alcoholics (Dorff et al., 1973) . In fact, at least 35% of nosocomial Klebsiella pneumonia has been reported in alcoholic patients, who can rapidly succumb to infection (Dorff et al., 1973; Jong et al., 1995) . Additionally, burn victims can be colonized by K. pneumoniae, which can readily progress into bacteremia (Ressner et al., 2008; Sharma et al., 2006) . Klebsiella pneumonia infections are becoming increasingly complicated with the rise in antibiotic-resistant strains around the world (Hosoglu et al., 2007; Oteo et al., 2008; Paterson, 2006; Tokatlidou et al., 2008) .
Due to the variety of infections caused by K. pneumoniae, several animal model systems including nonhuman primate intratracheal, mouse burn, rat urinary and systemic infections have been developed (Berendt et al., 1978; Cryz et al., 1984; Uehling & Wolf, 1969) . To study K. pneumoniae induced pneumonia in mice, both intratracheal and intranasal models of infection have been utilized (Lawlor et al., 2005; Shankar-Sinha et al., 2004) . During intratracheal infection, mice are anesthetized, and the trachea is surgically exposed for the delivery of bacteria. The LD 50 for both infection models are 2 9 10 3 (Lawlor et al., 2005; Shankar-Sinha et al., 2004; Yadav et al., 2003) . Twenty four hours postintranasal inoculation with 2 9 10 4 CFU bacterial burdens in the lungs and trachea reach levels of 1 9 10 7 CFU g À1 organs and by 24 h splenic colonization had been established with an average burden of 2.5 9 10 2 CFU g À1 spleen (Lawlor et al., 2005) . Mice succumbed to infection between 72 and 96 h. At this time, mice harbored burdens of 1 9 10 9 CFU g À1 organ in the trachea, lungs, and spleen (Lawlor et al., 2005) .
A major virulence factor associated with K. pneumoniae is a polysaccharide capsule, which protects the bacteria from phagocytosis, antimicrobial peptides, and neutrophilmediated killing (Campos et al., 2004; Domenico et al., 1994; Podschun & Ullmann, 1998; Williams et al., 1983) . Bacteria-lacking capsules are attenuated for virulence in pneumonic, subdermal, and renal murine infection models (Lawlor et al., 2005 (Lawlor et al., , 2006 Regue et al., 2004; Yoshida et al., 2001) . Additionally, mice intranasally inoculated with a capsule deficient mutant (cps À ) are protected from subsequent challenge with wild-type K. pneumoniae (Lawlor et al., 2006) . Capsule is not the only factor important for causing pneumonia. In fact, signature-tagged mutagenesis has revealed 106 loci necessary for colonization of the lung and spleen (Lawlor et al., 2005) . As antibiotic resistance becomes more prevalent, these data may help identify new targets for therapeutics to complement the dwindling number of efficacious drugs.
Burkholderia pseudomallei
There are several species of Burkholderia, three of which are important human pathogens most commonly found in the moist soil of Southeast Asia and northern Australia (Choy et al., 2000; Wiersinga et al., 2006) . Burkholderia cepacia (formerly Pseudomonas cepacia) generally infects the lungs of cystic fibrosis patients but is not thought to cause disease in healthy individuals (Harrison, 2007; Wiersinga et al., 2006) . Burkholderia thialandensis is normally considered a saprophyte not normally associated with disease (Wiersinga et al., 2006) . However, human infection with this organism has been reported (Glass et al., 2006) . Burkholderia pseudomallei is an opportunistic intracellular pathogen. It is of interest to note that B. mallei is believed to have recently evolved from B. pseudomallei through reductionist evolution as Y. pestis formed from Y. pseudotuberculosis (Achtman et al., 1999; Godoy et al., 2003) . Although B. pseudomallei is a much more prevalent human pathogen, this may represent a common theme in the evolution of pathogens. In addition, both B. pseudomallei and B. mallei have been listed by the CDC as category B agents (Cong et al., 2001) . As B. pseudomallei is more common human pathogen, and thus prominently studied, it will be the focus of this discussion.
Burkholderia pseudomallei has a broad host range and can infect animals such as goats and sheep as well as humans (Choy et al., 2000) . Infection is thought to occur through inhalation or open cuts can lead to severe pneumonia; and, subsequently, highly lethal septicemia can develop (Glass et al., 2006) . Seroprevalence in exposed populations are as high as 80% by 4 years of age (Kanaphun et al., 1993) . However, the vast majority of clinically relevant B. pseudomallei infections are in individuals between 40 and 60 years old generally with an underlying medical condition such as diabetes mellitus (White, 2003; Wiersinga et al., 2006) . These data highlight the fact the B. pseudomallei is an opportunistic pathogen.
Once in a host, B. pseudomallei enters host cells, exits the phagocytic vacuole, and replicates intracellularly (Harley et al., 1998) . Spread to neighboring cells is accomplished by actin polymerization-based motility (Harley et al., 1998; Wiersinga et al., 2006) . Burkholderia pseudomallei [but not B. thailandensis (Harley et al., 1998) ] contains at least three sequence clusters with high homology to the TTSS of S. typhimurium and S. flexneri (Rainbow et al., 2002; Stevens et al., 2002) . In the absence of several components of the putative TTSS B. pseudomallei showed diminished ability to form actin tails (Stevens et al., 2002) .
Aerosol or intranasal inoculation of mice with B. pseudomallei results in fulminant infection. Mice that received 4.5 9 10 3 CFU demonstrated systemic colonization by 48 h postinoculation with splenic and hepatic burdens reaching 1 9 10 3 -1 9 10 4 CFU g À1 organ in the spleen and liver and 1 9 10 6 CFU g À1 lung (Cuccui et al., 2007; Jeddeloh et al., 2003) . By 3 days postinoculation, colonization of the spleen and liver increased to 1 9 10 8 CFU g À1 organ and 1 9 10 9 CFU g À1 lung (Jeddeloh et al., 2003) . Mice infected with as little as 196 CFU succumbed to infection within 4 days (Jeddeloh et al., 2003) . STM analysis of B. pseudomallei identified 39 signature-tagged mutants attenuated in lung following intranasal inoculation; 22 were in capsular biosynthesis genes (Cuccui et al., 2007) . Seven other genes were involved in amino acid biosynthesis including, leucine, serine, and threonine (Cuccui et al., 2007) . Other mutagenesis studies have shown that amino acid auxotrophs for purine and histidine are also attenuated following intranasal infection (Pilatz et al., 2006) . These mutants were also attenuated for intracellular replication in cell culture, suggesting the intracellular lifestyle is essential for B. pseudomallei survival during the course of infection (Pilatz et al., 2006) . Interestingly, neither of these screens identified TTSS components as essential virulence factors, indicating that the screens did not saturate the genome, that the putative TTSS is not a required virulence mechanism in B. pseudomallei in this model of infection, or that they function redundantly.
Lung models of enteric Gram-negative pathogens
Salmonella Typhi
Salmonella Typhi is the causative agent of typhoid. Clinical manifestations include fever, delirium, diarrhea, and hepatosplenomegaly. According to the World Health Organization, there are an estimated 21 million cases of Salmonella Typhi worldwide each year (WHO, 2008) . Much has been learned my modeling the molecular pathogenesis of typhoid on animal models of S. typhimurium (Ohl & Miller, 2001) . Because Salmonella Typhi is host restricted to humans, orogastric infection in mice does not cause disease. However, because of its importance in global health, much emphasis has been placed on vaccine design and improvement. To this end, a pneumonic model of infection with Salmonella Typhi vaccine strain has been well characterized (Table 2 ; Galen et al., 1997; Pickett et al., 2000; Shi et al., 2010) .
Mice intranasally infected with 1 9 10 9 CFU of a Salmonella Typhi vaccine strain cleared bacteria from the lungs after 72 h. When an isogenic vaccine strain expressing tetanus toxin was used, mice generated robust immune responses to the protective antigen (Galen et al., 1997) . Additionally, Galen et al. intranasally or orogastrically infected mice with a Salmonella Typhi vaccine strain expressing a fusion protein of tetanus toxin. Intranasally infected mice developed a stronger immune response than those infected via the oral route. Similarly, mice intranasally infected with a Salmonella Typhi vaccine strain expressing the exogenous antigen pspA from S. pneumoniae developed a robust immune response to this antigen (Shi et al., 2010) . Together, these data demonstrate the validity and importance of pneumonic models of infection for vaccine development of host-restricted pathogens.
Shigella flexneri
Shigella spp. such as S. flexneri, S. dysenteriae, and to a lesser extend S. sonneii cause a debilitating bacterial dysentery in humans (Philpott et al., 2000) . Symptoms of Shigellosis generally include cramps, fever, in addition to purulent and bloody stool (Philpott et al., 2000) . Shigella is highly contagious and spreads via the fecal-oral route of infection (Phalipon & Sansonetti, 2007) . As few as 100 organisms of S. flexneri are capable of causing disease (DuPont et al., 1989; Phalipon & Sansonetti, 2003) . Animal models of pathogenesis, however, present difficulties in studying this tissue specificity and pathogenesis in general, as mice do not develop disease upon oral infection with Shigella (Philpott et al., 2000) . For instance, the rabbit ileal loop model is useful for studying S. flexneri invasiveness, but does not examine infection in the colon. Additionally, animals do not exhibit symptoms of dysentery. Despite this limitation much has been learned about the progression of disease from the available animal models and human studies (Mathan & Mathan, 1991; Menard et al., 1993; Philpott et al., 2000; Sereny, 1955) .
Shigella traverse the intestinal wall through specialized M cells (Philpott et al., 2000; Wassef et al., 1989 ). Transmigrated bacteria then enter epithelial layer through the basolateral side (Philpott et al., 2000) . Shigella move within the cytoplasm of host cells by polymerizing actin in an IcsA-dependent manner (Bernardini et al., 1989) . Shigella remains intracellular and spreads from cell to cell via actin-based motility dependent on IcsA (Philpott et al., 2000; Sansonetti, 1998) . Work in the rabbit ileal loop model shows those bacteria that traverse M cells often encounter macrophages, which phagocytose the bacteria. Shigella activates the apoptotic pathway and kills the engulfing host macrophage in an IpaB dependent manner (Philpott et al., 2000; Zychlinsky et al., 1994) . These host/pathogen interactions lead to the release of IL-8, an important chemokine for neutrophil recruitment (Sansonetti et al., 1999) .
In an effort to learn more about the host/pathogen interaction during Shigella infection, and in the absence of a suitable model to mimic human dysentery, work has been invested in the development of a pneumonic model of infection. Seminal work on this model began in the late 1950's (Voino-Yasenetsky & Voino-Yasenetskaya, 1962) . In these studies 113 white mice (strain not specified) were given 1 9 10 7 CFU of S. sonneii and 173 mice were inoculated with S. flexneri. By 48 h postinoculation, 83% of S. sonneii-infected mice succumbed to infection as did 74% of those mice infected with S. flexneri (Voino-Yasenetsky & Voino-Yasenetskaya, 1962) . Bacterial loads in the lungs of surviving mice by 48 h had diminished to 4 9 10 3 CFU per organ. Histopathological analysis of infected mice revealed an influx of neutrophils. Large numbers of the bacteria remained extracellular, but phagocytized bacteria were also observed. Importantly, bacteria were also noted to exist intracellularly within the epithelial cells of the lung.
It was proposed that IgA opsonization of Shigella in the intestinal lumen would facilitate the bactericidal activity of infiltrating neutrophils and resident macrophages and reduce bacterial infection (Phalipon et al., 1995) . Supporting this model, vaccination via the intranasal or orogastric route with proteosome-LPS complex from S. sonneii cross protects against subsequent intranasal challenge with S. flexneri or S. sonneii (Mallett et al., 1995) and that protection was associated with production of IgA and IL-6 (Mallett et al., 1993; Phalipon et al., 1995) . More recent work has revealed that transgenic BALB/c mice expressing IgA antibodies to Shigella LPS from an implanted hybridoma are less susceptible to subsequent intranasal infection (Phalipon et al., 1995) . These data highlight how the mucosal environment can be predictive of other mucosal immune environments. Additionally, they demonstrate the importance of the pneumonic models in vaccine development.
Campylobacter jejuni
Campylobacter jejuni is the causative agent of a self-limiting diarrhea in humans, which can last for several days to weeks and range in severity from loose stool to watery stool with mucus or blood. In rare cases, neuropathy can develop as the host immune responds to C. jejuni lipooligosaccarides. Our understanding of C. jejuni pathogenesis has been hampered by the lack of a mammalian animal model that mimics human disease. As part of the natural flora of avian species, chick models have allowed a much greater understanding of colonization of the gastrointestinal tract (Young et al., 2007) . However, experimental infection in this system does not induce disease. Infections in other hosts such as ferrets do induce disease (Fox et al., 1987) , but costs and lack of reagents make this model less tenable (Young et al., 2007) . Mice orally infected with C. jejuni clear the bacteria quickly. Like Shigella, C. jejuni infection induces IL-8 in humans. However, recently, a model has been developed in which SCID mice cleared of their natural flora were chronically colonized and inflammation of the gastrointestinal tissues induced, which will aid in future understanding of host response (Chang & Miller, 2006) . To complement existing models of pathogenesis, an intranasal model of C. jejuni infection was developed (Table 2 ; Baqar et al., 1996) . After intranasal inoculation of 1 9 10 9 CFU, lungs, stomach, large intestine, small intestine, liver, mesenteric lymph nodes, and spleen were all colonized by 6 h and declined over the course of 7 days. Whether the colonization of gastrointestinal tissues was due to direct colonization via postnasal drip or systemic spread cannot be determined. However, the fact that both the liver and spleen were colonized at early time points supports an argument for the latter. Six days after intranasal inoculation, 70% BALB/c mice, 50% C3H/HeJ mice, and 30% CBA/CAJ mice succumbed to infection. C58/J mice were more resistant and showed no mortality at this dose, and only 20% of mice succumbed with a dose of 1 9 10 10 (Baqar et al., 1996) . However, in a subsequent study, mortality in BALB/c mice was not observed even though the same strain of C. jejuni was used. This suggests there may have been technical differences between the two studies or laboratory-specific mutations (Al-Banna et al., 2008) . The lethality in C. jejuni-infected mice, however, correlates with the severity of the symptoms of the donor patient (Baqar et al., 1996) .
Recruitment of neutrophils in the gut is an important aspect of infection with Campylobacter in the chicken model of enteric infection (Fox et al., 1987) . Similarly, histopathology of the lung following intranasal infection includes the influx of neutrophils as well as foamy macrophages, bronchopneumonia, and the formation of granulomas (Al-Banna et al., 2008) . Intranasal infection with C. jejuni may allow for the study of interactions between bacteria and neutrophils in the context of a mucosal immune environment. Further work will allow for the elucidation of specific virulence factors or novel functions for those already known.
Vibrio cholerae
Vibrio cholerae is the causative agent of cholera, dysentery associated with profuse, watery diarrhea. Massive fluid loss can lead to dehydration and result in death without medical intervention. The study of V. cholerae has led to a great appreciation for the virulence factors necessary for causing disease. The rabbit ileal loop model, neonate mouse model, and studies from naturally or experimentally infected human cohorts have elucidated much about the pathogenesis of V. cholerae (Butler & Camilli, 2005; Butler et al., 2006; De & Chatterje, 1953; Freter & Gangarosa, 1963; Merrell et al., 2002 ). These models demonstrate the roles of classic virulence factors, such as cholera toxin (CTX) and toxin co-regulated pilus, as well as appreciating the role of physiological functions, such as chemotaxis in disease progression (Butler & Camilli, 2004; Lee et al., 1999) . In adult mice, V. cholerae is cleared from the gut without mimicking acute infection suffered by infected humans (Knop & Rowley, 1975a, b) , thus putting many tools made available by murine models out of reach. Fullner et al. developed a lung model of V. cholerae infection to determine infectivity. They tested the dependence of infectivity on known virulence factors and monitored the host immunological response (Table 2; Fullner et al., 2002) . Upon intranasal inoculation with 5 9 10 7 CFU of a CTX À strain, mice were reported to have demonstrated diffuse pneumonia associated with influx of neutrophils, hemorrhage, fibrination, and epithelial sloughing (Fullner et al., 2002) . This pathology could be alleviated by the removal of the gene encoding the endotoxin, RTX. This suggests that the inflammatory pneumonia observed is due to Vibrio-specific virulence factors and not simply toxicity due to the high bacterial input. However, removal of other known virulence factors such as the hemmagglutin/protease hapA or the hemolysin hlyA had no effect. Intranasal Vibrio infection also resulted in an increase in TNF, IL-6, and MIP-2. This inflammatory response was reduced in a stain lacking RTX. Although clearly not an exact model for human disease, these studies promise greater understanding of innate mucosal immune effectors in mature mice. It should be noted, however, that the these studies were carried out in the absence of functional CT, which has been shown to play an anti-inflammatory role tissue culture models (Cong et al., 2001) . It may be that in the presence of CT the inflammatory pneumonia would not be as evident following intranasal inoculation.
Enteric Yersinia
Robust orogastric and pneumonic animal models for Yersiniosis have been developed and characterized extensively (Fisher et al., 2007; Lathem et al., 2005; Logsdon & Mecsas, 2006) . Of the pathogens reviewed here, Yersinae, is the only genus for which both pneumonic and enteric modes of infection exist. We review these infection models to demonstrate the similarities and differences between established pneumonic model and enteric models of infection.
Three Gram-negative Yersinia bacteria cause various diseases in animals and humans. Yersinia pseudotuberculosis and Y. enterocolitica transmit themselves via a fecal-oral route of infection. Resulting infection leads to self-limiting gastroenteritis and lymphadenitis. Yersinia pestis, causes bubonic and pneumonic plague. All three Yersinia human pathogens harbor a 70 Kb virulence plasmid, which encodes a TTSS and associated translocated toxins, called Yops.
There are several reported human cases of pneumonic infection with Y. enterocolitica (Bigler et al., 1981; Girszyn et al., 2007) and one possible infection with Y. pseudotuberculosis (Hagiwara et al., 1995) . Furthermore, the protective properties of cellular extracts of Y. enterocolitica on subsequent intranasal challenge has been investigated (Di Genaro et al., 1998) . Following intranasal inoculation, with 5 9 10 6 CFU of serotype 0:8 Y. enterocolitica bacterial loads fell to 2 9 10 6 by 48 h but were associated with histopathology consistent with pneumonia (Di Genaro et al., 1998) . Although the LD 50 , mean time to morbidity, or ability to spread systemically in this model were not established, they did observe a twofold decrease in bacterial burden and no histopathology when mice were immunized with cellular extract prior to infection, suggesting a role for adaptive immunity in protecting against pneumonic Yersiniosis.
Experimental infection with Y. pseudotuberculosis with an initial inoculum of < 100 CFU colonized both BALB/c and Swiss Webster mice (Fisher et al., 2007) . This infection model was associated with high mortality. Furthermore, histopathology of the lungs in this model was consistent with pneumonia and included an influx of neutrophils and macrophages and tissue damage. However, dissemination to the spleen, liver and blood occurred sporadically and at lower burdens those observed in the lungs or by infection with Y. pestis (Table 1) . However, tissue colonization was dependent virulence factors known to be important for infection for Y. pestis. Although its efficacy was not tested, a humoral immune response was generated by mice surviving as demonstrated by IgG production. Additionally, this model has been subsequently used to screen small molecule inhibitors of the TTSS (Garrity-Ryan et al., 2010) . From this screen, two inhibitors were identified that reduced bacterial burden and limited the course of infection.
Concluding remarks
The pathogens discussed here can be divided into three categories: naturally occurring lung pathogens, opportunistic lung pathogens, and enteric pathogens. It is interesting that the first group is associated with a very low LD 50 , while the latter two groups (with the exception of Y. pseudotuberculosis) are associated with a relatively high LD 50 . These differences highlight the fact that although the lungs can act as a surrogate for sites of mucosal immunity, there are important differences between the lung and the GI tract in physical structure and local immune responses. With that in mind, murine lung models of pathogenesis allow for a greater understanding of the basic biology by which pathogens survive in pulmonary tissues as well as an understanding of the host response. Such insights offer invaluable information for the development of vaccines and novel therapeutics. Additionally, the pneumonic route of infection can be used as an alternate site of mucosal immunity for enteric pathogens for which there is not suitable models. Continued experimentation in this venue will inform how these pathogens elicit an immune response, and in some cases can predict immune responses during gastrointestinal infection.
